Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | KDM1A | O60341 | 2/20 | 0.41 |
| ▸ | PDE4A | P27815 | 2/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17527769 | 0.86 | L3MBTL1 (0.48) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL10909552 | 0.86 | ALDH1A1 (0.48) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL5205296 | 0.83 | ALDH1A1 (0.64) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL34472779 | 0.83 | KDM4E (0.36) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL9405807 | 0.81 | CYP1A2 (0.47) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL20226538 | 0.81 | CYP1A2 (0.47) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL4405598 | 0.81 | ALDH1A1 (0.45) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL1429875 | 0.77 | IDO1 (0.48) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL24240291 | 0.77 | L3MBTL1 (0.47) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E | |
| SCHEMBL16855852 | 0.77 | L3MBTL1 (0.42) | MAPTL3MBTL1ALDH1A1HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402041-B | Synthesis method of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-117402041-A | Synthesis method of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117402041-B | Synthesis method of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-117402041-B | Synthesis method of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-117599687-A | Synthesis device of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117599687-A | Synthesis device of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117402041-A | Synthesis method of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117402041-A | Synthesis method of 4-ethoxy-2, 3-difluorophenol | 浙江吉泰新材料股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| US-11760775-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. | 2023-09-19 | — | — | US | disclosed |
| US-20210040144-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2021-02-11 | — | — | US | disclosed |
| US-10711032-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2020-07-14 | — | — | US | disclosed |
| US-20180155389-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2018-06-07 | — | — | US | disclosed |
| US-9783539-B2 | Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors | JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC. (CN) | 2017-10-10 | — | — | US | disclosed |
| US-20170066761-A1 | INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS | JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC. (CN) | 2017-03-09 | — | — | US | disclosed |
| EP-3110815-A1 | INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS | Jiangsu Ascentage Biomed Development Inc. (CN) | 2017-01-04 | — | — | EP | disclosed |
| WO-2015127629-A1 | INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS | JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC. (CN) | 2015-09-03 | — | — | WO | disclosed |
| US-20150011528-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2015-01-08 | — | — | US | disclosed |
| EP-2758384-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Yuhan Corporation (KR) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013043001-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2013-03-28 | — | — | WO | disclosed |
| US-6403172-B1 | 6-HEXYLOXY-3-FLUORO-2-(4-HEXYLPHENYL) BENZO(B)THIOPHENE AS FERROELECTRIC SWITCHES OR DISPLAYING DEVICES; DIELECTRIC ANISOTROPY | CLARIANT INTERNATIONAL LTD. (CH) | 2002-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066761-A1 | INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS | ALK, BCL6, BCL6B | MAPT 1973/4885L3MBTL1 3986/4885ALDH1A1 821/4885 |
| US-20180155389-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | MAPT 3285/4885L3MBTL1 2840/4885ALDH1A1 4143/4885 |
| US-20150011528-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | ILK, PKMYT1, PLAUR | MAPT 813/4885L3MBTL1 1631/4885ALDH1A1 3792/4885 |
| US-10711032-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | MAPT 3285/4885L3MBTL1 2840/4885ALDH1A1 4143/4885 |
| US-20210040144-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | MAPT 2999/4885L3MBTL1 2855/4885ALDH1A1 4113/4885 |
| US-11760775-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | MAPT 2999/4885L3MBTL1 2855/4885ALDH1A1 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.